Personal tools
You are here: Home → With $1.1 Billion At Stake, Cancer Groups Mull “Comparative Effectiveness” Studies
Navigation
Subscribe or renew subscription
Google Ad Links
 

Send this page to somebody

Fill in the email address of your friend to send an email with the address.
Address info
(Required)
The e-mail address to send this link to.
(Required)
Your email address.
A comment about this link.
Log in


Forgot your password?
Top Headlines
« July 2010 »
Su Mo Tu We Th Fr Sa
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31
2010-07-02 00:00
00:00-00:00 Three Cooperative Groups To Combine Statistical Center Operations
2010-07-09 00:00
00:00-00:00 In Exit Interview, Niederhuber Says Clinical Trials System Must Refocus To Emphasize Translational Studies
2010-07-15 00:00
00:00-00:00 Harold Varmus Takes NCI Helm With No Promises, No Clichés
00:00-00:00 Prominent Duke Scientist Claimed Prizes He Didn't Win, Including Rhodes Scholarship
2010-07-23 00:00
12:00-12:00 Note to Cancer Letter Subscribers for Friday, July 23
14:40-14:40 The Potti Scandal: Biostatisticians Send Letter to Varmus, Lancet Oncology Expresses Concern
Categories:
FDA (16)
Medicare (4)
NCI (43)
cancer prevention (4)
cancer screening (19)
cancer treatment (16)
drug development (33)
legislation (6)
news makers (3)
oncology profession (12)
policy issues (31)
research funding (41)
Google Ads
 
Powered by Plone CMS, the Open Source Content Management System

This site conforms to the following standards: